Clinical Trials Browser

Phase 1 × Completed × giredestrant × Clear all

NCT03916744 2023-03-10

A Study of Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast Cancer

Phase 1 Completed

75 enrolled 24 charts

Breast Neoplasms